Comparison of stereotactic body radiotherapy and conventional external beam radiotherapy in renal cell carcinoma.

Authors

null

Christopher L. Tinkle

University of California, San Francisco, San Francisco, CA

Christopher L. Tinkle , Stephen Lawrence Shiao , Vivian K. Weinberg , Amy M. Lin , Alexander R. Gottschalk

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session C: Renal Cancer

Track

Renal Cell Cancer

Sub Track

Renal Cell Cancer

Citation

J Clin Oncol 33, 2015 (suppl 7; abstr 434)

DOI

10.1200/jco.2015.33.7_suppl.434

Abstract #

434

Poster Bd #

C26

Abstract Disclosures

Similar Posters

Poster

2019 Genitourinary Cancers Symposium

Outcomes of stereotactic ablative radiotherapy for extra-cranial oligo-metastatic renal cell cancer.

Outcomes of stereotactic ablative radiotherapy for extra-cranial oligo-metastatic renal cell cancer.

First Author: Yuanyuan Zhang

Poster

2023 ASCO Genitourinary Cancers Symposium

Natural history of patients with muscle metastases from renal cell carcinoma: Results of the French national ARTEMIS study.

Natural history of patients with muscle metastases from renal cell carcinoma: Results of the French national ARTEMIS study.

First Author: Mylene Wespiser

Poster

2019 Gastrointestinal Cancers Symposium

Local control following stereotactic body radiotherapy to adrenal oligometastases.

Local control following stereotactic body radiotherapy to adrenal oligometastases.

First Author: Nicholas B Figura

Poster

2016 Genitourinary Cancers Symposium

External beam radiotherapy and concurrent gemcitabine for muscle-invasive bladder cancer: Toxicities and early outcomes.

External beam radiotherapy and concurrent gemcitabine for muscle-invasive bladder cancer: Toxicities and early outcomes.

First Author: Elana Nack